GH Insider Trading Activity and SEC Form 4 Filings
GH insider trading summary
Over the past 12 months, insiders at Guardant Health, Inc. (GH) reported 140 sales worth $172.4M by 15 insiders and 1 open-market purchase worth $78K by 1 insider on SEC Form 4. Net insider selling was $172.3M.
Latest GH insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Oct 16, 2026 | Musa Tariq | Director | Sell | $19K (116 @ $165.88) |
| Oct 14, 2026 | Alex M Azar II | Director | Sell | $11K (69 @ $159.89) |
| Sep 16, 2026 | Alex M Azar II | Director | Sell | $145K (826 @ $175.00) |
| Sep 16, 2026 | Steve E. Krognes | Director | Sell | $192K (1,103 @ $174.46) |
| Sep 16, 2026 | Steve E. Krognes | Director | Sell | $579K (3,300 @ $175.42) |
| Sep 16, 2026 | Musa Tariq | Director | Sell | $20K (116 @ $175.00) |
| Sep 16, 2026 | Steve E. Krognes | Director | Sell | $172K (971 @ $177.48) |
| Sep 16, 2026 | Steve E. Krognes | Director | Sell | $229K (1,300 @ $176.34) |
| Sep 15, 2026 | Darya Chudova | Chief Technology Officer | Sell | $1.4M (7,738 @ $178.00) |
| Sep 11, 2026 | Kumud Kalia | Chief Information Officer | Sell | $632K (4,000 @ $158.05) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.